Vantin: Targeted Antibiotic Therapy for Bacterial Infections
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.72 | $81.73 (0%) | 🛒 Add to cart |
| 60 | $2.25 | $163.45 $135.20 (17%) | 🛒 Add to cart |
| 90 | $2.10 | $245.18 $188.68 (23%) | 🛒 Add to cart |
| 120 | $2.03 | $326.91 $243.16 (26%) | 🛒 Add to cart |
| 180 | $1.95 | $490.36 $350.11 (29%) | 🛒 Add to cart |
| 270 | $1.89
Best per pill | $735.54 $511.55 (30%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.14 | $124.10 (0%) | 🛒 Add to cart |
| 60 | $3.43 | $248.21 $205.83 (17%) | 🛒 Add to cart |
| 90 | $3.20 | $372.31 $287.56 (23%) | 🛒 Add to cart |
| 120 | $3.08 | $496.41 $369.28 (26%) | 🛒 Add to cart |
| 180 | $2.97 | $744.62 $533.74 (28%) | 🛒 Add to cart |
| 270 | $2.88
Best per pill | $1116.93 $777.92 (30%) | 🛒 Add to cart |
Synonyms
| |||
Vantin (cefpodoxime proxetil) is an advanced, third-generation oral cephalosporin antibiotic designed to treat a wide spectrum of bacterial infections. It functions by inhibiting bacterial cell wall synthesis, leading to the eradication of susceptible pathogens. This medication is prescribed for conditions including community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, uncomplicated skin and skin structure infections, acute otitis media, pharyngitis, tonsillitis, and uncomplicated urinary tract infections. Its broad-spectrum activity and reliable pharmacokinetic profile make it a cornerstone in outpatient antimicrobial therapy, offering clinicians a potent option for managing common to moderately severe bacterial diseases.
Features
- Active Ingredient: Cefpodoxime proxetil, a prodrug hydrolyzed to active cefpodoxime
- Drug Class: Third-generation cephalosporin antibiotic
- Available Forms: Oral tablets (100 mg, 200 mg) and granules for suspension (50 mg/5 mL, 100 mg/5 mL)
- Spectrum of Activity: Effective against Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis
- Dosing Flexibility: Adjustable dosing based on infection type, severity, and renal function
- Administration: Can be taken with or without food, though absorption is enhanced with a meal
Benefits
- Broad-Spectrum Efficacy: Provides reliable coverage against common respiratory, skin, and urinary tract pathogens, reducing the need for multiple antibiotics.
- Convenient Dosing Regimen: Typically administered twice daily, supporting adherence and simplifying treatment schedules for outpatients.
- High Tissue Penetration: Achieves effective concentrations at sites of infection, including lung tissue, skin, and middle ear fluid.
- Well-Tolerated Profile: Generally associated with a low incidence of severe adverse effects when used as directed.
- Proven Clinical Success: Demonstrated high cure rates in clinical trials for approved indications, reinforcing its role in empirical and directed therapy.
- Oral Bioavailability: Allows for effective transition from intravenous therapy or outright avoidance of hospitalization in eligible patients.
Common use
Vantin is indicated for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms. Common uses include:
- Community-Acquired Pneumonia: Caused by Streptococcus pneumoniae or Haemophilus influenzae (non-beta-lactamase producing strains).
- Acute Bacterial Exacerbations of Chronic Bronchitis: Attributable to Streptococcus pneumoniae, Haemophilus influenzae (non-beta-lactamase producing strains), or Moraxella catarrhalis.
- Uncomplicated Skin and Skin Structure Infections: Caused by Staphylococcus aureus (including penicillinase-producing strains) or Streptococcus pyogenes.
- Acute Otitis Media: In pediatric patients caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains), or Moraxella catarrhalis.
- Pharyngitis and Tonsillitis: Caused by Streptococcus pyogenes.
- Uncomplicated Urinary Tract Infections: Caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus.
Dosage and direction
Dosage of Vantin must be individualized based on the infection being treated, its severity, and the patient’s renal function. It is typically administered orally every 12 hours.
Adults and adolescents (age 12 years and older):
- Pneumonia: 200 mg every 12 hours for 14 days.
- Bronchitis: 200 mg every 12 hours for 10 days.
- Skin Infections: 400 mg every 12 hours for 7–14 days.
- Pharyngitis/Tonsillitis: 100 mg every 12 hours for 5–10 days.
- Uncomplicated UTI: 100 mg every 12 hours for 7 days.
Pediatric Patients (based on body weight for suspension):
- Otitis Media: 10 mg/kg/day (maximum 400 mg per day) divided every 12 hours for 10 days.
- Pharyngitis/Tonsillitis: 10 mg/kg/day (maximum 200 mg per day) divided every 12 hours for 5–10 days.
Renal Impairment: In patients with creatinine clearance less than 30 mL/min, the dosing interval should be increased to every 24 hours. For patients on hemodialysis, dosing should occur after each dialysis session.
Tablets should be swallowed whole. The oral suspension should be shaken well before each use. Administration with food may enhance absorption and is recommended.
Precautions
- Hypersensitivity: Use with caution in patients with a history of hypersensitivity reactions to penicillins or other beta-lactam antibiotics, due to potential cross-reactivity.
- Clostridium difficile-Associated Diarrhea: Antibiotic use can result in overgrowth of C. difficile, leading to diarrhea ranging from mild to life-threatening colitis. Discontinue use if diarrhea develops.
- Renal Impairment: Dosage adjustment is necessary in patients with moderate to severe renal insufficiency (creatinine clearance <30 mL/min).
- Prolonged Use: May result in superinfection or fungal overgrowth. Use the shortest effective duration.
- Phenylketonurics: The oral suspension contains phenylalanine (a component of aspartame); consider alternative formulations in patients with phenylketonuria.
- Laboratory Tests: May cause a false-positive reaction for glucose in the urine using copper reduction tests (e.g., Benedict’s, Fehling’s, or Clinitest®); use glucose-specific tests (e.g., Clinistix®).
Contraindications
Vantin is contraindicated in patients with:
- Known hypersensitivity to cefpodoxime, other cephalosporins, or any component of the formulation.
- A history of anaphylactic reactions to penicillins or other beta-lactam antibiotics.
Possible side effect
Common side effects are generally mild and may include:
- Gastrointestinal: Diarrhea, nausea, vomiting, abdominal pain
- Dermatological: Rash, pruritus
- Neurological: Headache
- Genitourinary: Vaginal mycosis or vaginitis
Less common but more serious side effects require medical attention:
- Severe diarrhea (possibly C. difficile)
- Allergic reactions: urticaria, itching, difficulty breathing, swelling of face/lips/tongue/throat
- Stevens-Johnson syndrome or toxic epidermal necrolysis
- Hepatotoxicity: jaundice, dark urine
- Blood dyscrasias: unusual bleeding/bruising, signs of infection
Drug interaction
- Probenecid: May inhibit renal excretion of cefpodoxime, increasing serum levels and prolonging half-life.
- Antacids and H2 Blockers: Can reduce absorption of cefpodoxime; administer at least 2 hours apart.
- Other Antibiotics: Potential antagonism with bacteriostatic antibiotics (e.g., tetracyclines, erythromycin).
- Oral Contraceptives: Antibiotics may reduce efficacy of estrogen-containing contraceptives; advise use of alternative non-hormonal contraception during therapy.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric distress, and diarrhea. In cases of significant overdose, particularly in patients with renal impairment, neurological reactions (e.g., seizures) may occur. Treatment is supportive and symptomatic. Hemodialysis may aid in removing cefpodoxime from the bloodstream.
Storage
- Store tablets at controlled room temperature (20°–25°C or 68°–77°F); excursions permitted to 15°–30°C (59°–86°F).
- Keep in a tight, light-resistant container.
- Reconstituted oral suspension may be stored for 14 days at room temperature or under refrigeration; do not freeze. Discard any unused portion after 14 days.
- Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and post-marketing surveillance indicate Vantin is effective and well-tolerated. In trials for acute otitis media, clinical success rates exceeded 85%. For respiratory tract infections, bacteriologic eradication rates were consistently high. Most adverse events were mild and self-limiting. Patient-reported outcomes often note convenience of twice-daily dosing and overall satisfaction with treatment course results. As with all antibiotics, resistance patterns should guide therapy.